Page 66 - AN-3-1

Advanced Neurology Dementia with Lewy bodies and substance misuse

disease. Handb Clin Neurol. 2008;89:189-192. antioxidant molecule against metal-induced oxidative
doi: 10.1016/S0072-9752(07)01217-1 damage. J Neurosci. 2002;22(12):4833-4841.
doi: 10.1523/JNEUROSCI.22-12-04833.2002
53. Dugger BN, Adler CH, Shill HA, et al. Concomitant
pathologies among a spectrum of Parkinsonian disorders. 65. Surmeier DJ, Obeso JA, Halliday GM. Selective neuronal
Parkinsonism Relat Disord. 2014;20(5):525-529. vulnerability in Parkinson disease. Nat Rev Neurosci.
2017;18(2):101-113.
doi: 10.1016/j.parkreldis.2014.02.012
doi: 10.1038/nrn.2016.178
54. Werner CJ, Heyny-von Haussen R, Mall G, Wolf S. Proteome
analysis of human substantia nigra in Parkinsons disease. 66. Lautenschläger J, Stephens AD, Fusco G, et al. C-terminal
Proteome Sci. 2008;6:8. calcium binding of α-synuclein modulates synaptic vesicle
interaction. Nat Commun. 2018;9:712.
doi: 10.1186/1477-5956-6-8
doi: 10.1038/s41467-018-03111-4
55. Schaser AJ, Osterberg VR, Dent SE, et al. Alpha-
synuclein is a DNA binding protein that modulates DNA 67. Erskine D, Koss D, Korolchuk VI, Outeiro TF, Attems J,
repair with implications for Lewy body disorders. Sci McKeith I. Lipids, lysosomes and mitochondria: Insights
Rep. 2019;9(1):10919. into Lewy body formation from rare monogenic disorders.
Acta Neuropathol. 2021;141(4):511-526.
doi: 10.1038/s41598-019-47227-z
doi: 10.1007/s00401-021-02266-7
56. Emanuele M, Chieregatti E. Mechanisms of alpha-synuclein
action on neurotransmission: Cell-autonomous and non- 68. Lee HJ, Baek S, Ho DH, et al. Dopamine promotes formation
cell autonomous role. Biomolecules. 2015;5(2):865-892. and secretion of non-fibrillar alpha-synuclein oligomers.
Exp Mol Med. 2011;43:216-222.
doi: 10.3390/biom5020865
doi: 10.3858/emm.2011.43.4.026
57. Südhof TC, Rizo J. Synaptic vesicle exocytosis. Cold Spring
Harb Perspect Biol. 2011;3(12):a005637. 69. King E, O’Brien JT, Donaghy P, et al. Peripheral inflammation
in prodromal Alzheimer’s and Lewy body dementias.
doi: 10.1101/cshperspect.a005637
J Neurol Neurosurg Psychiatry. 2018;89(4):339-345.
58. Lücking CB, Brice A. Alpha-synuclein and Parkinson’s
disease. Cell Mol Life Sci. 2000;57(13-14):1894-1908. doi: 10.1136/jnnp-2017-317134
70. Shams R, Banik NL, Haque A. Calpain in the cleavage of
doi: 10.1007/PL00000671
alpha-synuclein and the pathogenesis of Parkinson’s disease.
59. Man WK, Tahirbegi B, Vrettas MD, et al. The docking of Prog Mol Biol Transl Sci. 2019;167:107-124.
synaptic vesicles on the presynaptic membrane induced doi: 10.1016/bs.pmbts.2019.06.007
by α-synuclein is modulated by lipid composition. Nat
Commun. 2021;12:927. 71. Tan LY, Tang KH, Lim LYY, Ong JX, Park H, Jung S.
α-synuclein at the presynaptic axon terminal as a double-
doi: 10.1038/s41467-021-21027-4
edged sword. Biomolecules. 2022;12(4):507.
60. Hettiarachchi NT, Parker A, Dallas ML, et al. alpha-Synuclein
modulation of Ca2+ signaling in human neuroblastoma doi: 10.3390/biom12040507
(SH-SY5Y) cells. J Neurochem. 2009;111(5):1192-1201. 72. Adamczyk A, Strosznajder JB. Alpha-synuclein potentiates
Ca2+ influx through voltage-dependent Ca2+ channels.
doi: 10.1111/j.1471-4159.2009.06411.x
Neuroreport. 2006;17(18):1883-1886.
61. Huang M, Wang B, Li X, Fu C, Wang C, Kang X. α-Synuclein: doi: 10.1097/WNR.0b013e3280115185
A multifunctional player in exocytosis, endocytosis, and
vesicle recycling. Front Neurosci. 2019;13:28. 73. Loveland PM, Yu JJ, Churilov L, Yassi N, Watson R.
Investigation of inflammation in Lewy body dementia:
doi: 10.3389/fnins.2019.00028
A systematic scoping review. Int J Mol Sci. 2023;24(15):12116.
62. Hou X, Watzlawik JO, Fiesel FC, Springer W. Autophagy in doi: 10.3390/ijms241512116
Parkinson’s disease. J Mol Biol. 2020;432(8):2651-2672.
74. Myers AJ, Brahimi A, Jenkins IJ, Koob AO. The synucleins
doi: 10.1016/j.jmb.2020.01.037
and the astrocyte. Biology (Basel). 2023;12(2):155.
63. Dickson DW. Alpha-synuclein and the Lewy body disorders. doi: 10.3390/biology12020155
Curr Opin Neurol. 2001;14(4):423-432.
75. Scarlata S, Golebiewska U. Linking alpha-synuclein
doi: 10.1097/00019052-200108000-00001y
properties with oxidation: A hypothesis on a mechanism
64. Zou K, Gong JS, Yanagisawa K, Michikawa M. A novel underling cellular aggregation. J Bioenerg Biomembr.
function of monomeric amyloid β-protein serving as an 2014;46(2):93-98.

Volume 3 Issue 1 (2024) 14 https://doi.org/10.36922/an.2232